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Abstract 
Vaccine hesitancy during the COVID-19 pandemic has been an issue in the Latino 
community since the approval of the emergency use of the Moderna and Pfizer vaccines. Latino 
patients from a community health clinic in Oakland, CA have expressed their hesitancy. Only 
47% of patients 65 years and older at the community health clinic received the COVID-19 
vaccine. With COVID-19 disproportionately affecting this community, focusing on prevention 
through the uptake of a COVID-19 vaccine is necessary. A microsystem assessment concluded 
the need for the improvement of patient outreach via calls. This project seeks to examine if 
standardizing the patient outreach process through phone calls promotes vaccine uptake in 
patients over four weeks. Findings from the literature review suggest that the multimodal 
intervention proposed in this project will increase vaccine uptake among patients. Components of 
the intervention include motivational interviewing, standardization of the outreach process, and 
documentation. The evaluated outcome will be scheduled vaccine appointments prior to the 
intervention compared to scheduled vaccine appointments after implementation of the 
intervention. It is difficult to change human behavior, therefore, the focus on improving the 
patient outreach process with the recommendations provided in this quality improvement project 
can serve as a foundation from which a health institution, such as a community clinic, can forge 
an intervention that better suits the needs of the population it serves. 
 Keywords: Vaccine Hesitancy, Vaccine, Latino, Hispanic, Outreach, Vaccine Uptake, 
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Improving COVID-19 Vaccination Uptake in the Latino Community Through 
Standardized Outreach 
March 2020 marked the beginning of an unexpected pandemic in the United States of 
America. The COVID-19 virus has taken the lives of hundreds of thousands of people with 
treatment and prevention being an obstacle. Particularly, the Latino community, or people of 
Latin American origin or descent, has been impacted with the Centers for Disease Control and 
Prevention (CDC) reporting that “Latino people are hospitalized because of the virus four times 
the rate of White Americans” (CDC, 2020, para 3). Additionally, according to the National Center 
for Health Statistics (2020), Latinos are 2.3 times as likely to die from COVID-19 compared to 
white Americans. This can be due to a combination of many factors that have resulted in 
overexposure of the virus and susceptibility. Some of the factors that have contributed to the 
incidence rate and impact of COVID-19 among the Latino population include employment, health 
insurance, socioeconomic status, sick leave/paid leave or employee benefits, family size, 
household size, comorbidities, cultural/traditional beliefs and values, and mistrust.  
The mistrust in the government is a rhetoric that has been created as a result of the Latino 
people being painted in a negative light during President Trump’s presidency, which contributed 
to an anti-immigrant sentiment, discrimination, and dehumanization (King & Lopez-Cevallo, 
2020). Historically, there has been structural racism and medical malpractice towards 
communities of color in the United States. For example, the “sterilization of Puerto Rican women 
and Mexican men and women” still remains as inhumane events in American history (Sanchez & 
Pena, 2021, para 2). Additionally, the maltreatment of Latinos in the immigrant detention centers 
has left many wounds for this community. The fear and exclusion felt by this community has 
IMPROVING COVID-19 VACCINATION UPTAKE 5 
resulted in distrust. When there is mistrust in the government and affiliated organizations, such as 
the CDC, it makes it much harder to combat a pandemic. 
In order to reduce the spread and transmission of the deadly COVID-19 virus, prevention 
is vital. However, many Latinos rely on information from media sources such as television and 
radio as well as informal sources such as family members and social support networks (Castaneda 
& Diaz., 2017; Torres et al., 2016).  Misinformation and the media have contributed to the distrust 
of communities and their leading bodies to the point that some have even questioned the severity 
of the virus. Now that there is a leading option for COVID-19 prevention, which is vaccination, 
the Latino community, especially those aged 65 years or older, are hesitant. In the United States, 
the CDC assessed the intent of COVID-19 vaccination among groups prioritized for early 
vaccination and found that only 36.4% of the Hispanic/Latino ethnic group had the intent to 
vaccinate (Nguyen et al., 2021). Vaccinating high risk groups, especially the ethnic groups that 
have been largely affected, such as the Latino community, is a priority to reduce the mortality and 
morbidity rates. Ultimately, vaccination is the solution for eradicating this pandemic. However, 
trust has to be regained and education has to be provided by health care clinics, primary 
providers, and healthcare professionals to encourage vaccine uptake. Additionally, the processes 
and procedures for vaccination should be patient-centered, coordinated, and evidence-based to 
optimize effectiveness.  
 Due to the health insurance disparity between Latinos and non-Latino White Americans, 
many Latinos seek medical care from community clinics or community hospitals (Castaneda & 
Diaz, 2017). The COVID-19 pandemic has affected community health clinics in particular 
because community health clinics have had to adjust to a new way of providing healthcare 
services with the use of telemedicine. While for some medical practices and facilities 
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telemedicine is seen as a solution, telemedicine is a barrier for patient populations served by 
community health clinics due to technology literacy levels being low among these communities 
and the inaccessibility to devices that enable telemedicine visits. This could exacerbate health 
disparities among already vulnerable populations.  
 In the United States, barriers to telemedicine are more frequently found in “rural 
populations, older adults, racial/ethnic minority populations, and those with low socioeconomic 
status, limited health literacy, and limited English proficiency” (Nouri et al., 2020, para 1). After 
exploring potential disparities because of the transition to telemedicine primary care visits during 
the COVID-19 pandemic, Nouri et al. (2020) found the proportion of visits with populations at 
risk for limited technology literacy/access have decreased significantly. Specifically, patient visits 
decreased significantly among the patient groups > 65 years old, non-English language 
preference, and insured by Medicare or Medicaid (Nouri et al., 2020). A decrease in patient visits 
has contributed to a loss of revenue among clinics. Community health clinics in California are 
operating based on the Department of Public Health’s recommendations and policies. In order to 
return to normality and increase patient census, patients need to be vaccinated to ensure the safety 
of staff and other people in the clinic.  
Problem Description 
A community health clinic in Oakland, California serves primarily the Latino community. 
The clinic is equipped with Spanish speaking staff to enable the provision of culturally competent 
and patient centered care. In the Family Medicine Unit, many of the patients have chronic 
conditions and comorbidities. This puts this patient population at higher risk for complications if 
these patients become infected with COVID-19. Providers have been recommending the Moderna 
and Pfizer vaccines after they were approved by the FDA for emergency use to patients based on 
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their eligibility tier. However, data from informational interviews with staff from the community 
health clinic indicated that there is vaccine hesitancy stemming from fear and misinformation 
surrounding the vaccines. According to the clinic manager of the community health clinic, only 
47% of patients ages 65 years and older at the clinic have decided to get the vaccine. This leaves 
53% of patients in this age group who refused and did not get the vaccine. Community members, 
patients, and their loved ones continue to be at risk for the virus. 
To address the issue of vaccine hesitancy, a microsystem assessment was completed to 
gain a better understanding of the issue. Originally, there were issues in the operational process of 
the vaccine clinic because patients needed to complete all documentation on paper. Based on site 
observations, this resulted in long wait times for patients and an inefficient process. In order to 
address this issue, a cloud-based platform called Primary.Health, was implemented to streamline 
the registration process. After implementation of Primary.Health, the wait times have decreased, 
and the overall efficiency of the registration process has improved, based on site-specific 
observations. Another area of improvement that was identified through the microsystem 
assessment was patient outreach and education. Informational interviews with staff suggest that 
the current patient outreach process being utilized by the clinic is fragmented and uncoordinated. 
Patient calls are lacking standardized education about the vaccines and so misinformation and 
myths are not able to be corrected. Some patients have been called on three separate occasions 
and patients have not tolerated the calls, which has been demonstrated by patient complaints 
about the calls and resistance to speak about the vaccine. Due to patients being unsatisfied with 
the patient calls, the clinic decided to discontinue patient outreach calls regarding COVID-19 
vaccination. This is an important opportunity to better understand the reasons for hesitancy in 
order to properly tailor evidence-based interventions that would promote vaccine uptake.  
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Available Knowledge 
PICOT Question 
 After completing the microsystem assessment, conducting informational interviews with 
clinic staff and leadership, and identifying areas for improvement to aid in the vaccine uptake of 
the Latino patients of the community health clinic, a PICOT question was established. A PICOT 
question is a formulated question that encompasses the population, intervention, comparison, 
outcome, and timeline. For this project, the PICOT question posed is: In patients who are 
receiving a phone call to schedule a COVID-19 vaccine appointment, will educating the staff on a 
multimodal, standardized outreach intervention compared to the current outreach process improve 
COVID-19 vaccine uptake in 4 weeks?  
Literature Search 
 Two databases were utilized to explore the effectiveness of multimodal interventions in 
addressing vaccine hesitancy in February 2021. The databases used in the search were PubMed 
and CINAHL Complete. The search terms or keywords used for searching the databases were: 
vaccine hesitancy, vaccine, Latinx, Latino, Hispanic, outreach, vaccine uptake, interventions, 
education, evidence-based, quality improvement. There were a limited number of articles that 
pertained to the Latinx or Latino community, specifically. Additionally, many of the articles 
focused on the Human Papilloma Virus (HPV) and the Influenza or flu vaccines. Due to COVID-
19 being a relatively new virus, psychosocial studies that pertain to COVID-19 vaccine uptake 
and hesitancy are very limited. Only peer-reviewed articles published no earlier than 2016 were 
reviewed. Additionally, the focus of the search was on articles that contained evidence-based 
interventions to encourage vaccine uptake and reduce vaccine hesitancy. These articles were used 
for the review. 
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Literature Synthesis 
 The literature search provided recommendations for reducing vaccine hesitancy by using a 
multimodal intervention approach as there are many factors that affect vaccine hesitancy and 
uptake (Falcone et al., 2020; Reno et al., 2018; Tan, 2018). For example, some factors that affect 
vaccine hesitancy and uptake are political ideology, perceived risk of infection, educational 
level/attainment, age, and socioeconomic status (Baumegaertner et al., 2020). A study conducted 
by Sevin et al. (2016) in a clinic that serves an urban, underserved, and multicultural community 
in Ohio found that the top five influencers in vaccine uptake among patients were: “doctor’s 
recommendation, knowing why they should get a vaccine, knowing which vaccines they need, 
cost, and concern about getting sick if they get a vaccine” (p. 1). Thus, these findings support the 
implementation of interventions that improve provider-patient communication as well as 
highlights the importance of the primary provider’s role in providing patient education regarding 
vaccines (Reno et al., 2018). Furthermore, patients will be more receptive to vaccination if the 
benefits and indications for the vaccine were promoted, which is beneficial information for 
patients with chronic conditions (Sevin et al., 2016).  
 Patient education and effective communication are two components that are necessary 
when introducing something new to a patient. Patient education needs to be individualized and 
strategic. For example, educating the patient about the vaccine preventable disease is important to 
include in the conversation (Guzman-Holst et al., 2020). Additionally, motivational interviewing 
is an evidence-based intervention that has been effective in increasing vaccination uptake (Reno 
et al., 2018; Wallace-Brodeur et al., 2020). Having staff trainings to improve workflow patterns 
and on how to effectively recommend vaccines to patients with the use of motivational 
interviewing techniques can aid in reducing vaccine hesitancy (Falcone et al., 2020; Wallace-
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Brodeur et al., 2020). Changes in decision support and documentation, such as recording patient 
refusal, were associated with an increase in influenza vaccination uptake in a primary care clinic 
in Illinois (Persell et al., 2020). Apart from staff training on motivational interviewing and 
communication techniques with vaccine hesitant patients, Kappa et al. (2020) recommends 
utilizing a call-center as a cost-effective and efficient way to increase patient satisfaction and 
organizational performance.  
Understanding that communities have differences in regard to vaccination behavior and 
beliefs are extremely important to consider when implementing an intervention for a specific 
community. With the knowledge we have about the Family Medicine Unit patient population at 
the community health clinic and its vaccination process, recommendations from the literature can 
be appropriately integrated into this project.  
Rationale 
Change Theory 
 To guide this quality improvement project, Kurt Lewin’s Change Theory will be used. 
This change theory encompasses three major concepts: driving forces, restraining forces, and 
equilibrium (Petiprin, 2020). The driving forces push for change to occur, whereas restraining 
forces are considered the barriers to change. The concept of equilibrium is when the driving 
forces and restraining forces equal each other and therefore, change is unable to occur (Petiprin, 
2020). In order to stimulate change, Kurt Lewin’s Change Theory incorporates three phases to 
push the driving forces to overcome the restraining forces.  
 The three phases are unfreezing, change, and refreezing. In the unfreezing phase, the need 
for change is proposed and the restraining forces or barriers to change are addressed and 
mitigated. The current patient outreach process that was observed in the community health clinic 
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is unstandardized and fragmented. This contributes to the issue of vaccine hesitancy in patients. 
Therefore, demonstrating the ineffectiveness of the current process is key to stimulate change. 
Showing the benefits of having a standardized and coordinated outreach process may also help 
staff consider the proposed changes. In this phase, group behaviors that divert to a new direction 
will be increased (Hussain et al., 2018). Once the driving forces, such as staff buy-in, are greater 
than the restraining forces, the change phase will occur, whether it be change in thoughts, 
perspective, or behavior. When the change is implemented, it is desired for the new patient 
outreach process to be adopted as a new habit and thus the refreezing phase occurs. The 
refreezing phase allows for the change or new process to be reinforced to prevent any increase in 
restraining forces or people reverting back to the old behavior.  
Model for Improvement 
 Another framework that is recommended by the Institute for Healthcare Improvement to 
be utilized for accelerating improvement is called the Model for Improvement. According to 
Langley et al. (2009), this framework is an integrated approach to process improvement that can 
be applied to diverse settings. This model has two parts. The first part entails addressing three 
fundamental questions, which aid in setting aims, establishing measures, and selecting changes 
(Langley et al., 2009). The second part is the Plan Do Study Act (PDSA) cycle to test changes in 
the setting. Multiple PDSA cycles may be required to test a change until the desired improvement 
is achieved. The community health clinic’s lack of organized process improvement contributed to 
patient vaccine hesitancy. As explained by the clinic manager, patients received multiple calls 
from the clinic from different staff regarding the COVID-19 vaccine without being provided 
individualized education and patients became upset and more resistant to getting vaccinated. This 
example demonstrates the importance of having a coordinated outreach effort that is person-
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centered. By using the Model for Improvement framework, intentional steps for improvement can 
be taken such as planning the change and intervention, implementing the change, studying the 
change’s effectiveness, and acting upon the findings from the evaluation to determine if the 
change needs to be revised to complete another PDSA cycle or if the PDSA cycle is terminated 
because the desired outcomes were met. 
Project Aim 
 With this project, we aim to improve COVID-19 vaccine uptake among Latino patients at 
a community health clinic in Oakland, California. By working on the patient outreach process, we 
expect increased nurse efficacy, improved nurse-patient communication, increased knowledge 
about COVID-19 and the vaccine among patients, a decrease in stigma or misinformation 
surrounding vaccinations, a decrease in COVID-19 infection, and increased vaccine uptake. It is 
important to work on this now because we are in the middle of a COVID-19 pandemic and the 
COVID-19 vaccines are crucial in preventing COVID-19 infection and transmission, especially 
among communities that have been disproportionately affected by COVID-19. 
Methods 
Context 
 The Clinical Nurse Leader works within the microsystem to provide direct patient care as 
well as works to support, guide, and educate nurses in the improvement of processes and 
procedures with the utilization of evidence-based practices (Harris et al., 2018). The process of 
improvement begins by conducting a microsystem assessment. A microsystem assessment is a 
unit needs assessment that identifies unit strengths and weaknesses as well as enables the Clinical 
Nurse Leader to objectively identify areas for improvement. Valuable information was obtained 
from the microsystem assessment and site observations conducted in the Family Medicine Unit. 
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Further data and information were obtained from informational interviews with the community 
health clinic’s staff and leadership. 
PDSA Cycles 
The 5P framework that incorporates the unit specific assessment of purpose, patients, 
professionals, processes, and patterns is used to guide the microsystem assessment.  The 
microsystem assessment indicated areas of improvement for both the vaccination clinic’s 
operational process and the patient outreach process. The community health clinic had 
completed a few PDSA cycles without evaluating the change implemented and so new PDSA 
cycles were implemented that lacked evidence-based practices and coordination. In the 
vaccination clinic’s operational process, the registration portion was an area identified as 
needing improvement. The community health clinic implemented the use of a cloud-based 
software called Primary.Health to shift all patient documentation and registration from paper to 
a digital format. Patients are now completing their registration forms via Primary.Health on 
their phones or other technological device that has access to internet. This has reduced patient 
wait times, reduced paperwork, and has improved the overall efficiency of the vaccination 
process. With the improvements made in the vaccination process, our direction shifted to focus 
on the patient outreach and education process.  
For the patient outreach process, medical assistants and nurses began calling eligible 
patients for vaccine appointment scheduling. They were met with resistance as these patients 
were not interested in getting the COVID-19 vaccine. Providers in the clinic were then 
encouraged to call the same patients to give their recommendation of the vaccine. Providers 
were also met with resistance. Patients received multiple calls from clinic staff regarding 
vaccination. There are various reasons for the hesitancy, many of which stem from fear and 
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misinformation. The healthcare professionals calling the patients did not use motivational 
interviewing techniques and did not provide individualized education about the vaccine during 
the calls. The uncoordinated effort to call patients for vaccine promotion left patients frustrated 
with the staff, which resulted in increased refusal of the vaccine as well as the clinic’s decision 
to abandon patient outreach via phone calls. This is an area that needs improvement.   
Prior to patient outreach via phone calls being abandoned, a patient survey was created 
with the hopes that it would be implemented during patient outreach calls to better understand 
the reasons for vaccine hesitancy as well as to understand the sources of information that the 
patients refer to for information regarding COVID-19 and the vaccine. This survey can be 
found in Appendix A. By implementing this survey, educational efforts as well as overall 
outreach efforts could be better tailored to the community’s specific needs. Additionally, due to 
lack of individualized and standardized education being provided to patients regarding the 
vaccine, an educational resource was created to support staff in answering common questions 
about the vaccine. This resource, which can be found in Appendix B, can also be used to dispel 
vaccine myths and misinformation.   
Patient frustration and hesitancy increased as clinical staff continued to call regarding a 
COVID-19 vaccination appointment. Thus, phone calls to patients for this reason were 
discontinued. The community health clinic was not using this opportunity with their patients 
effectively, thus the need for standardizing and coordinating patient outreach efforts became 
apparent. With this project being completed primarily in a remote setting due to clinic COVID-
19 policies and the inability to implement the desired intervention through patient phone calls, 
the quality improvement project direction shifted to a hypothetical project. With the review of 
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literature and evidence-based practices, a multimodal intervention to address vaccine hesitancy 
to promote vaccine uptake is proposed in this hypothetical project.  
SWOT 
 A Strengths, Weaknesses, Opportunities, and Threats (SWOT) analysis, found in 
Appendix C, was used to assess what has been working well in the community health clinic and 
what needs work in order to effectively implement change to improve the patient outreach 
process. Strengths of the organization that were identified were having skilled and knowledgeable 
staff, having existing educational materials, having a well-known community health clinic with 
multiple departments that can be used as a resource such as Behavioral Health and Health 
Coaching, and having access to county and CDC information and guidance. Organizational 
weaknesses that were identified consisted of financial limitations due to a budget that has been 
negatively affected by this pandemic, loss of revenue due to limited in-person operations, and 
weekly changes to the vaccination and phone call process to address the evolving COVID-19 
situation. Examples of some opportunities that were identified are support from local community-
based clinics in the county as well as outreach in local churches, grocery stores, schools, and 
senior centers to raise awareness, combat misinformation, and provide education to community 
members. Threats to improving this process consist of constant evolvement of processes due to 
new data and information being disseminated, changing vaccine eligibility tiers, fluctuating 
vaccine supply, media misinformation, and patients refusing education about the vaccine.  
Cost-Benefit Analysis 
 Healthcare facilities, especially community health clinics, were deeply affected financially 
by this pandemic. Specifically, this Oakland community health clinic, which serves 90,000 people 
a year, suffered huge revenue losses when the pandemic prompted them to stop patient visits to 
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mitigate the spread of COVID-19 (Katoni & Sparling, 2020). Katoni and Sparling (2020) further 
explain that the community health clinic lost over $3,000,000 monthly in revenue during 2020. 
With the transition to telehealth medical visits, the underserved communities served by this 
community health clinic may not benefit from these types of visits because of inaccessibility to 
technology or low technology literacy levels. Many of the patients of this community health clinic 
benefit from the support and interaction received during in-person visits as many patients need 
health education and assistance with monitoring their blood pressure, blood sugar, or medications. 
By promoting COVID-19 vaccination among these communities, it is expected to have a decrease 
in COVID-19 infection to ultimately deem it safe for the community health clinic to open its 
doors again to in-person visits. In-person visits are something that the patients as well as the clinic 
desperately needs. By having a Clinical Nurse Leader develop the educational materials and 
training for the nursing staff to improve the patient outreach process for COVID-19 vaccine 
appointments, the community health clinic can take a step forward towards seeing patients in 
person. The total costs for a Clinical Nurse Leader to develop and conduct staff trainings to ten 
registered nurses is $1149.39, as demonstrated in Appendix D. This cost is minimal compared to 
the $3,000,000 in monthly revenue loss. By having patients vaccinated, the safety of the clinic can 
be evaluated for in-person visits to reduce losses and increase revenue.   
Intervention 
The literature suggests using a multimodal intervention to increase vaccine uptake 
because vaccine hesitancy is a complex issue. Thus, our intervention includes implementation 
of a script for nurses to use during patient calls aimed at scheduling vaccine appointments. The 
script incorporates the use of motivational interviewing techniques, which are shown in 
Appendix G, to guide the person-centered, individualized education that would be provided 
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during the call. Information about the benefits of the vaccine as well as the risks and 
consequences of the COVID-19 virus should also be shared with patients during this call. The 
staff would refer to the educational resource in Appendix B for information the patients may 
inquire about or to dispel misinformation. For patients that are vaccine hesitant, implementing a 
vaccine-hesitancy survey, such as in Appendix A, will help determine the reasons for vaccine 
hesitancy as well as the sources of information the patients refer to. Lastly, standardized 
documentation of the telephone encounter with the patient into EPIC is a key component to 
facilitate with identifying patterns or trends. Essentially, with our multimodal intervention we 
are improving workflow, nurse efficacy in the topic, communication between patient and 
healthcare professional, and are obtaining data on vaccine hesitancy for the next PDSA cycle. 
With the data from the vaccine hesitancy survey, evident in Appendix A, we can revise the 
educational script as well as use the collected information to revise outreach efforts to better 
meet the needs of the community. Our desired outcome is to have this multimodal intervention 
result into a scheduled COVID-19 vaccination appointment. We will measure vaccine uptake 
rates for patients that partook in our intervention to determine our intervention’s effectiveness. 
The Gantt chart in Appendix E shows the timeline of the project with the components that are 
hypothetical.  
Measures 
 To study the effectiveness of this multimodal intervention, the PDSA cycles will be 
used. The PDSA cycles are rapid cycles that test for change with a phase of evaluation and 
revision. Thus, the intervention can be adjusted or changed if necessary. A measure to also 
determine the effectiveness of the proposed intervention is to compare the number of scheduled 
appointments for COVID-19 vaccination before and after implementation of the intervention. A 
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patient feedback survey will also be mailed out, texted, or emailed to the patient after their 
phone call with the healthcare professional to be completed at a later time. This survey can be 
referred to in Appendix F. By including the patient perspective, the intervention can be 
modified, if needed, for a new PDSA cycle. Audits in the electronic health record that is used 
by the community health clinic called EPIC will give the Clinical Nurse Leader the opportunity 
to identify any patterns or trends related to vaccine hesitancy and vaccine uptake. These audits 
will be conducted by the Clinical Nurse Leader to determine proper documentation of patient 
calls and adherence to the intervention.  
Results 
 The inability to implement the proposed intervention and the shift to a hypothetical 
project led to the reliance of results obtained from the literature. Reno et al. (2018) 
implemented an intervention that included motivational interviewing and a fact sheet, which 
resulted in a reported high parental Human Papilloma Virus vaccine acceptance of 75% 
compared to 46% of acceptance among the control group. These two components of the 
intervention were reported by providers as the most useful and easiest to implement. Sevin et 
al. (2016) recommends including information about the benefits and indications for vaccines in 
conversations between healthcare professionals and patients after their study showed that 
patients respond more positively toward vaccines when this type of information is included. 
Streamlined documentation combined with other evidence-based interventions to improve 
workflow and communication led to a 57% increase in influenza uptake in a clinic for the 
uninsured (Falcone et al., 2020). Furthermore, staff training on how to effectively recommend 
the HPV vaccine has been a major contributor to vaccine uptake (Wallace-Brodeur et al., 2020). 
Ethical Considerations 
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 This project was fulfilled at an Oakland, California community health clinic as an 
evidence-based change project and was approved as a quality improvement project by 
University of San Francisco faculty using quality improvement review guidelines. The 
completed Statement of Non-Research Determination Form, which can be referred to in 
Appendix H, contains more information about this project being an evidence-based project. 
Therefore, this project does not require IRB approval.  
 Ethical considerations were utilized for this project. Two ethical principles that are 
addressed are autonomy and the right to self-determination. With autonomy, the health care 
professional has to respect and support the patient’s decision for what will be done with their 
own person. According to the American Nurses Association (2015), the right to self-
determination is the patient’s moral and legal right to determine what will be done to their own 
person and to be given the complete and accurate information to facilitate an informed decision. 
With the proposed intervention, healthcare professionals will have the training and resources to 
be prepared to inform patients about the benefits, side effects, indications, and contraindications 
for the vaccine as well as educate patients about the consequences and risks of COVID-19. The 
educational resource will also help healthcare professionals dispel misinformation or myths that 
patients may share during the conversation or may be affected by. Misinformation spread by 
the media and by word of mouth have largely contributed to vaccine hesitancy, as mentioned by 
the clinic’s leadership during an informational interview. Thus, ensuring that the patient is fully 
informed about the vaccine as well as the virus are essential. The healthcare professional has to 
respect and support the patient’s decision on vaccination regardless of the healthcare 
professional’s wishes for the patient. However, the healthcare professional should do their due 
diligence by ensuring the patient is fully informed to make their decision. 
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Discussion 
Implications for Practice 
 This project can serve as a resource and example of how to approach patients when 
discussing something new, such as a vaccine. The importance of staff buy-in when 
implementing a change and having a coordinated process is demonstrated. With COVID-19 
being prevalent with new variants and herd immunity being something to work towards, 
COVID-19 will not be eliminated anytime soon. Thus, this project can be used as a resource for 
future COVID-19 prevention and eradication projects.  
Barriers  
 Some barriers could be contributed to the remote nature of this project. This project was 
completed remotely apart from the initial phase, which was the microsystem assessment, in order 
to respect the COVID-19 regulations in the community health clinic that were advised by the 
public health department. The community health clinic’s priorities were to their patients and staff 
during this unprecedented time of the COVID-19 pandemic, which is understandable. Resources 
were put towards fighting this pandemic through the operation of the vaccination clinic. This 
resulted in the clinic being short staffed, and current staff being pulled from their regular roles to 
assist with vaccination efforts. With so much on the staff’s plates and the remote nature of this 
project, communication between the clinic leadership and the members of this project was 
ineffective. For example, students participating in this project were not fully informed of clinical 
changes that were occurring at a rapid pace and this led to project delays and unexpected changes. 
This created difficulties for this project to be completed efficiently and effectively. Another 
barrier was the inability to implement the proposed intervention due to clinic’s decision to 
discontinue patient outreach via phone calls. Therefore, the effectiveness of the proposed 
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intervention for this particular community and patient population could not be evaluated. The 
limited time period for this project also served as a barrier because only 3-4 months could be 
dedicated to the entirety of the project.  
Recommendations 
 It is recommended that this project be implemented and completed onsite when the 
eligibility tier is consistent such as when everyone, who is not contraindicated, is eligible for 
vaccination. A project with this scope and type of intervention should also be implemented in 
person or onsite rather than remotely to effectively evaluate all portions of the project. 
Additionally, it is important to assess the site of implementation’s readiness for change to 
determine staff buy-in and support before continuing with project.  
Limitations  
 There were several limitations to this project. One limitation of the project was the 
changing eligibility tiers for vaccination. For example, vaccine hesitancy can vary among age 
groups; thus, it would be difficult to measure the effectiveness of our intervention with eligibility 
tiers allowing younger demographics to become vaccinated. There is also lack of historical 
evidence of COVID-19 and vaccines due to new viral discovery and vaccine development. 
Additionally, the data used to propel this project was obtained from onsite observations and was 
based on the perspective of four staff members with different responsibilities and perspectives in 
the community health clinic. 
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Conclusion 
 The COVID-19 pandemic has disproportionately affected the Latino community and in 
order to combat this pandemic, vaccination is highly encouraged. However, the community health 
clinic in Oakland, California had an uncoordinated and unstandardized outreach process that 
resulted in increased patient frustration that contributed further to the already existing vaccine 
hesitancy among these patients. This led to patient outreach being discontinued, which is 
unfortunate and not recommended. By improving the patient outreach process through 
standardization and coordination of a multimodal, evidence-based intervention, vaccine uptake 
among the Latino community is strongly expected to increase. Although this project was unable 
to be fully implemented at the site, based on the literature review findings, it is expected that the 
proposed intervention in this project would be successful. It is recommended to implement the 
intervention and continue to evaluate the intervention through the completion of PDSA cycles. By 
increasing vaccine uptake among this community, risk of transmission can be reduced, and the 
clinic can move forward with in-person patient visits that greatly benefit both the patients and the 
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Appendix A 
Patient Vaccine Hesitancy Survey  
1. Where do you get your information about COVID-19 from? De donde obtiene su 
información sobre el COVID-19?  
 
2. What do you know about COVID-19? ¿Qué sabe acerca del COVID-19? 
 
3. Have you tested positive for COVID-19? ¿Ha dado positivo en la prueba de COVID-19? 
 
4. Where do you get your information about the COVID-19 vaccine from? De donde obtiene 
su información sobre la vacuna para el COVID-19? 
 
5. What do you know about the COVID-19 vaccine?  ¿Qué sabe acerca de la vacuna? 
 
6. Do you have any concerns about the COVID-19 vaccine? Tiene preguntas o 
preocupaciones acerca de la vacuna del COVID-19? 
 
7. Are you aware of your eligibility for the COVID-19 vaccine? Usted sabe si es elegible 
para la vacuna contra el COVID-19?  
 
Yes: How did you know about your eligibility? ¿Cómo supo de su elegibilidad? 
  No: Do you know how to find information about your eligibility? ¿Sabe cómo  
   encontrar información sobre su elegibilidad? 
 
8. Do you receive other recommended vaccines like the flu vaccine? ¿Recibe otras vacunas 
recomendadas como la vacuna contra la gripe? 
 
9. Have you been recommended to get the COVID-19 vaccine? Le han recomendado recibir 
la vacuna contra el COVID-19? 
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Appendix B 
 
Patient Education Resource 
 
Patient Responses/Statements Health Professional Response 
How do we know that these vaccines 
are safe when they are so new? 
Couldn’t they cause problems that we 
don’t know about yet? What about 
long-term problems?  
COVID-19 vaccines are being tested in large clinical 
trials to assess their safety. However, it does take time, 
and more people getting vaccinated before we learn 
about very rare or long-term side effects. That is why 
safety monitoring will continue. CDC has an 
independent group of experts that reviews all the safety 
data as it comes in and provides regular safety updates. 
If a safety issue is detected, immediate action will take 
place to determine if the issue is related to the COVID-
19 vaccine and determine the best course of action. 
Can COVID-19 vaccine make me sick 
with COVID-19? 
No. None of the authorized and recommended 
vaccines contain the live virus that causes COVID-10. 
This means the vaccine cannot make you sick with 
COVID-19. 
 
There are several different types of vaccines in 
development. All of them teach our immune systems 
how to recognize and fight the virus that causes 
COVID-19. Sometimes this process can cause 
symptoms. These symptoms are normal and a sign that 
the body is building protection against the virus that 
causes COVID-19.  
Will a COVID-19 vaccine alter my 
DNA? 
No. MRNA vaccines do not change or interact with 
your DNA in any way. mRNA vaccines teach our cells 
how to make a protein that triggers an immune 
response. COVID-19 mRNA vaccines work with the 
body’s natural defenses to safely develop immunity to 
disease.  
Is there a microchip in the vaccine? No, there is no microchip in the vaccine. These claims 
are baseless and false. The vaccine vials have a list of 
ingredients made clear so consumers can read them. 
These are also accessible via the internet. 
How much will the shot hurt? Your arm may be sore, red, or warm to the touch. 
These symptoms usually go away on their own within 
a week.  
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After getting a COVID-19 vaccine, 
will I test positive for COVID-19 on a 
viral test 
No. Neither the recently authorized and recommended 
vaccines nor the other COVID-19 vaccines currently in 
clinical trials in the United States can cause you to test 
positive on viral tests, which are used to see if you 
have a current infection 
The COVID-19 vaccine was rushed to 
the market or the science was rushed. 
The COVID-19 vaccines from Pfizer/BioNTech and 
Moderna were created with a method that has been in 
development for years, so the companies could start 
the vaccine development process early in the pandemic 
 
China isolated and shared genetic information about 
COVID-19 promptly, so scientists could start working 
on vaccines. 
The vaccine developers didn’t skip any testing steps, 
but conducted some of the steps on an overlapping 
schedule to gather data faster. 
Vaccine projects had plenty of resources, as 
governments invested in research and/or paid for 
vaccines in advance. 
Some types of COVID-19 vaccines were created using 
messenger RNA (mRNA), which allows a faster 
approach than the traditional way that vaccines are 
made. 
Social media helped companies find and engage study 
volunteers, and many were willing to help with 
COVID-19 vaccine research. 
Because COVID-19 is so contagious and widespread, 
it did not take long to see if the vaccine worked for the 
study volunteers who were vaccinated. 
The vaccine affects fertility in 
women. 
Confusion arose when a false report surfaced on social 
media, saying that the spike protein on this coronavirus 
was the same as another spike protein called syncitin-1 
that is involved in the growth and attachment of the 
placenta during pregnancy. The two spike proteins are 
completely different and distinct, and getting the 
COVID-19 vaccine will not affect the fertility of 
women who are seeking to become pregnant, including 
through in vitro fertilization methods. During the 
Pfizer vaccine tests, 23 women volunteers involved in 
the study became pregnant, and the only one who 
suffered a pregnancy loss had not received the actual 
vaccine, but a placebo. 
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I’ve already had COVID-19, so I 
don’t need to get the vaccine.  
People who have gotten sick with COVID-19 may still 
benefit from getting vaccinated. Due to the severe 
health risks associated with COVID-19 and the fact 
that re-infection with COVID-19 is possible, people 
may be advised to get a COVID-19 vaccine even if 
they have been sick with COVID-19 before. 
 
Yes, you should be vaccinated regardless of whether 
you already had COVID-19. That’s because experts do 
not yet know how long you are protected from getting 
sick again after recovering from COVID-19. 
The side effects of COVID-19 
vaccine are dangerous. 
The COVID-19 vaccine can have side effects, but the 
vast majority are very short term —not serious or 
dangerous. The vaccine developers report that some 
people experience pain where they were injected; body 
aches; headaches or fever, lasting for a day or two. 
These are signs that the vaccine is working to stimulate 
your immune system.  
I won’t need to wear a mask after I 
get the vaccine 
-It may take time for everyone who wants a COVID-
19 vaccination to get one 
-While the vaccine may prevent you from getting sick, 
it is unknown at this time if you can still carry and 
transmit the virus to others. Until more is understood 
about how well the vaccine works, continuing with 
precautions such as mask-wearing and physical 
distancing will be important. 
You can delay routine vaccinations 
until after the pandemic is over  
No, you should keep up to date with any important 
adult vaccinations and ensure children are kept up to 
date as well. There are ways to ensure decreased risk 
of exposure and still allow you to get necessary 
vaccines.    
I heard the vaccine can alter the 
results of my mammogram. I am 
concerned - does this mean the 
vaccine will give me breast cancer?  
No, the vaccine will not give you breast cancer. The 
reports regarding mammogram results being 
influenced by the COVID vaccine are based on the 
potential side effect of swollen lymph nodes. There are 
lymph nodes located in the breasts, and the vaccine 
may cause them to swell. This is not uncommon, and it 
is a normal response to the vaccine. If you plan on 
having a mammogram soon after receiving the 
vaccine, please contact your provider to let them know 
about your appointment.  
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The COVID-19 vaccine was 
developed with or contains 
controversial substances 
The first two COVID-19 vaccines to be authorized by 
the FDA contain mRNA and other, normal vaccine 
ingredients, such as fats (which protect the mRNA), 
salts, as well as a small amount of sugar. These 
COVID-19 vaccines were not developed using fetal 
tissue, and they do not contain any material, such as 
implants, microchips or tracking devices. 
Will it interfere with any 
medications? 
The vaccine should not interfere with most common 
medications like blood pressure medications, diabetes 
medications, and thyroid medications. If you are on 
immunosuppressant medications (chemotherapy, high 
dose steroids), it is important to ask your doctor about 
specific medications.    
Will it be safe for people with low or 
high blood pressure? High 
cholesterol? 
Yes, this vaccine is safe in people with medical 
conditions like high blood pressure, DM, and high 
cholesterol. Patients with all of these conditions were 
included in the vaccine trials.   
Is it safe for older people? Yes, the vaccine is safe in people of all ages >18yo for 
Moderna. More than 20% of the patients in each of the 
trials were older than 65% years. It is especially 
important to get vaccinated if you are older given how 
dangerous the virus can be in the elderly/   
If you are allergic to egg (flu vaccine) 
can you still get the COVID vaccine? 
Yes, there are no egg products in the vaccine so you 
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Appendix G 
Motivational Interviewing Techniques 
When beginning a motivational interviewing session, many healthcare organizations, including 
both Harvard Pilgrim and the American Academy of Family Physicians (AAFP), advocate for the 
use of the OARS acronym: 
• Open-ended questions 
• Affirmations (expressing empathy and celebrating even small successes) 
• Reflective listening (repeating words back to patients) 
• Summarizing 
 
The AAFP advocates the following principles during motivational interviewing: 
• Motivation to change is elicited from the patient, not imposed from outside 
• It is the patient's task, not the healthcare professional’s, to resolve their ambivalence 
• Direct persuasion is not an effective method for resolving ambivalence 
• The counseling style is a quiet one, with a focus on eliciting the patient's thoughts 
• The healthcare professional is directive in helping the patient examine and resolve 
ambivalence 
• Readiness to change is not a patient trait but a fluctuating product of interpersonal 
interaction 
• The therapeutic relationship is more like a partnership or companionship; expert/recipient 
roles can impede the process 
• Elicit pros and cons of change 
• Inquire about the importance and confidence of making a change  
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10 Strategies for Motivational Interviewing 
 
Strategy #1: Ask a question that will prompt change to talk as an answer. For example, “What 
are some things you can do to make sure you are keeping yourself and your family safe during 
this pandemic?” 
 
Strategy #2: Ask for the pros and cons of both changing and staying the same. For example, 
“How will getting the vaccine lower your risk of infection and hospitalization? How will having a 
sick family member impact you?” 
 
Strategy #3: Ask about the positives and negatives of the target behavior. For example, “How 
will getting the vaccine improve your wellbeing? What are the negative impacts of getting the 
vaccine (e.g., cost, side effects)?” 
 
Strategy #4: When the patient expresses change-talk, ask for more details. For example, “In what 
ways? Tell me more? When was the last time that happened?” 
 
Strategy #5: Ask what may happen if the patient makes the changes according to their care 
management plan. For example, “If you follow all of the CDC guidelines and recommendations, 
what will be different? How do you see your health five years from now?” 
 
Strategy #6: Ask about extreme outcomes. For example, “What are the worst things that might 
happen if you don’t get the vaccine? What are the best things that might happen if you get the 
vaccine?” 
 
Strategy #7: Offer ways to clearly measure the impact of vaccination. For example, “On a scale 
from one to 10 (where one is not at all important and a 10 is extremely important), how important 
is it to improve your health? What do you think you can do to get closer to a 10?” 
 
Strategy #8: Ask about the patient’s main health goals. For example, “Do you want to be healthy 
enough to travel to this summer? What upcoming family events do you want to attend?” 
 
Strategy #9: Think like the patient and reframe any barriers into a positive strategy. For example, 
“Getting to the vaccination site seems to be like a hassle. How about we organize an Uber to 
transport you to and from the vaccination site instead?” 
 
Strategy #10: Optional versus announcement recommendation: Instead of “have you thought 
about what shots you’d like to schedule today?” say, “We have some shots to do today”. This 
implies shot is important and most people get it.  
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Motivational Interviewing Example 
 
HCP: “Today, we have the COVID-19 vaccine available for you. The specific vaccine we have is 
…” 
 
Patient: “I don’t want the COVID-19 vaccine.” 
 
Step 1: Ask patient to share concerns 
 
HCP: “So you seem to have questions about the COVID-19 vaccine. I want to make sure I answer 
all your questions, so let’s talk about it. Would you mind sharing what your particular concerns 
are?” 
 
Patient: “Well I heard it’s not safe and I’m worried about the side effects. I also heard I will get 
coronavirus through the vaccine.” 
 
Step 2: Ask permission to share information. The provider reflects back what the parent is saying 
to be sure he/she understands (empathy), summarizes, and asks permission to share their own 
perspective.  
 
HCP: “So I hear that you’re concerned about the COVID-19 vaccine’s side effects and that you 
will get the coronavirus through the vaccine. I have also heard some stories about this vaccine, 
and I follow vaccine safety closely. Is it okay if I go over what I know about this vaccine? 
 
Step 3: Provide information to change the patient's perspective. Avoid arguing and focus on 
disease prevention. 
 
“Side effects are a possible risk with any pharmaceutical you introduce to your body, such as 
medications and vaccines. It is not guaranteed that you will experience side effects. The side 
effects for the COVID-19 vaccine usually last about 1-3 days after they start. However, having 
the side effects shows that your body is working hard to develop immunity to the virus. The side 
effects for this vaccine are flu-like symptoms such as fever, headache, body aches, chills, and 
fatigue. If you are experiencing side effects, you can take over the counter medication to help with 
your symptoms, such as Tylenol or Advil. 
 
There have also been many stories about the vaccine. One of them being that we are injecting the 
virus into you. I have been following the safety of this vaccine as well as have studied how it’s 
made. This vaccine does not have the virus in it. It uses an MRNA technology that helps your 
body create antibodies that will also be able to respond to the coronavirus if you are exposed. I 
have treated many patients who got very sick from diseases we can prevent with vaccines. There 
are many complications with COVID-19. Can you tell me about some of the complications 
you’ve heard about? 
 
Step 4: Make a personalized recommendation to schedule a vaccination appointment. 
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“I strongly believe in this important vaccine, which is why I got vaccinated and I recommend it to 
all my patients. I think you should schedule an appointment to receive it today.  Having said that, 
this is a decision that only you can make. What do you think? 
 
Tips for declination or delay: 
 
1. Let the patient know you will offer it again at a later time.  
2. Offer reading material or educational resources 
3. Relax- you’ve done your best 
 
Most people may be interested in getting vaccinated but may have questions. 
A strong and confident vaccine recommendation works. 
Try motivational interviewing techniques for vaccine hesitant patients.  
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Appendix H 
 
Project: Statement of Determination and Non-Research Determination Form 
Student Name: Bianca De La Piedra 
Title of Project: Reducing Vaccine Hesitancy Among the Latinx Patients in La Clinica 
de la Raza 
Brief Description of Project: Integrating education and outreach to increase vaccination 
rates among patients at La Clinica de la Raza 
 
Data that Shows the Need for the Project 
Only a 47% vaccination rate was achieved by La Clinica patients in the age group 65 
years old and older. After speaking with stakeholders in the organization, education is 
lacking during patient calls to schedule COVID-19 vaccination appointments. As the 
eligibility tiers to get the COVID-19 vaccine begin to change, outreach efforts and 
education need to be adjusted to more effectively target the current eligible groups. 
 
Aim Statement 
We aim to improve the process of outreach and education at La Clinica de la Raza Transit 
Village in order to increase COVID-19 vaccination rates amongst eligible groups.  
The process begins with assessment of the 5 Ps. The process ends with increased patient 
vaccination rates. By working on the process, we expect to determine motivational factors 
for receiving or denying the vaccine at the La Clinica site, implement patient education to 
be provided by staff during patient calls to schedule vaccination appointments, and 
normalize the vaccine with improving outreach efforts. It is important 
to work on this now because La Clinica de la Raza has a patient population that is largely 
Latinx, undocumented, individuals with chronic illnesses, and low-income 
who are also disproportionately affected by the virus. We want to encourage patients 
to receive the vaccine as soon as possible to prevent the spread of COVID-19. 
 
Description of Intervention(s) Improve patient education during patient calls by 
generating a script or workflow for staff and normalize vaccine with outreach efforts 
appropriate for the clinic population 
 
Desired Change in Practice Enable staff to answer patient questions about the vaccine 
and to dispel myths about the vaccine to encourage vaccine uptake; improve 
communication between vaccine hesitant patients and staff through implementation of 
motivational interviewing techniques during patient outreach calls; standardized and 
coordinated outreach process with proper documentation. 
 
Outcome measurement(s) Vaccination rates before and after intervention will be 
compared. 




To qualify as an Evidence-based Change in Practice Project, rather than a Research Project, the 
criteria outlined in federal guidelines will be used:  (http://answers.hhs.gov/ohrp/categories/1569)  
☐   This project meets the guidelines for an Evidence-based Change in Practice Project as 
outlined in the Project Checklist (attached). Student may proceed with implementation. 
☐This project involves research with human subjects and must be submitted for IRB approval 
before project activity can commence. 
Comments:   
EVIDENCE-BASED CHANGE OF PRACTICE PROJECT CHECKLIST * 
Instructions: Answer YES or NO to each of the following statements: 
Project Title:  YES NO 
The aim of the project is to improve the process or delivery of care with 
established/ accepted standards, or to implement evidence-based change. 
There is no intention of using the data for research purposes. 
x  
The specific aim is to improve performance on a specific service or program 
and is a part of usual care.  ALL participants will receive standard of care. 
x  
The project is NOT designed to follow a research design, e.g., hypothesis 
testing or group comparison, randomization, control groups, prospective 
comparison groups, cross-sectional, case control). The project does NOT 
follow a protocol that overrides clinical decision-making. 
x  
The project involves implementation of established and tested quality 
standards and/or systematic monitoring, assessment or evaluation of the 
organization to ensure that existing quality standards are being met. The 
project does NOT develop paradigms or untested methods or new untested 
standards. 
x  
The project involves implementation of care practices and interventions that 
are consensus-based or evidence-based. The project does NOT seek to test 
an intervention that is beyond current science and experience. 
x  
The project is conducted by staff where the project will take place and 
involves staff who are working at an agency that has an agreement with USF 
SONHP. 
x  
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The project has NO funding from federal agencies or research-focused 
organizations and is not receiving funding for implementation research. 
x  
The agency or clinical practice unit agrees that this is a project that will be 
implemented to improve the process or delivery of care, i.e., not a personal 
research project that is dependent upon the voluntary participation of 
colleagues, students and/ or patients. 
x  
If there is an intent to, or possibility of publishing your work, you and 
supervising faculty and the agency oversight committee are comfortable with 
the following statement in your methods section: “This project was 
undertaken as an Evidence-based change of practice project at X hospital or 





ANSWER KEY: If the answer to ALL of these items is yes, the project can be considered an 
Evidence-based activity that does NOT meet the definition of research.  IRB review is not 
required.  Keep a copy of this checklist in your files.  If the answer to ANY of these questions 
is NO, you must submit for IRB approval. 
 
*Adapted with permission of Elizabeth L. Hohmann, MD, Director and Chair, Partners Human 
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